cyanocobalamin

(redirected from Nascobal)
Also found in: Dictionary, Thesaurus, Medical.

cyanocobalamin:

see coenzymecoenzyme
, any one of a group of relatively small organic molecules required for the catalytic function of certain enzymes. A coenzyme may either be attached by covalent bonds to a particular enzyme or exist freely in solution, but in either case it participates intimately in
..... Click the link for more information.
; vitaminvitamin,
group of organic substances that are required in the diet of humans and animals for normal growth, maintenance of life, and normal reproduction. Vitamins act as catalysts; very often either the vitamins themselves are coenzymes, or they form integral parts of coenzymes.
..... Click the link for more information.
.

Cyanocobalamin

 

(or Vitamin B12), C63H88CoN14O14P, a cobalt-corrin complex in which the cobalt atom is bonded to a cyano group, a nucleotide residue, and four reduced pyrrole rings; molecular weight, 1355.40. Cyanocobalamin is a dark-red crystalline compound, which is soluble in water and polar organic solvents. It was first isolated in crystalline form from cattle liver. Its structure was established by A. Todd and D. Crowfoot Hodgkin and their co-workers.

The primary sources of cyanocobalamin in nature are microorganisms; cyanocobalamin is synthesized by several bacteria, by actinomycetes, and by blue-green algae. It occurs in almost all animal tissues. It is not encountered, as a rule, in the tissues of higher plants (legume tubers are an exception). In ruminants, it is synthesized in sufficient amounts by the microflora of the intestine and the rumen. In man and several higher animals, such as birds and hogs, its synthesis by intestinal microflora is insufficient, and thus the vitamin must be obtained from food. The daily requirement for humans is about 5 μg. The major sources of the vitamin are liver, kidneys, fish meal, and milk.

In the form of its coenzymes methylcobalamin and deoxyadenosylcobalamin, cyanocobalamin participates in the enzymic reactions involved in hematopoiesis and facilitates normal liver function and nerve fiber regeneration. It is produced by microbiological synthesis using propionic-acid bacteria for the fermentation process.

Vitamin B12 is used for the treatment of pernicious anemia and other anemias, as well as of diseases of the central and peripheral nervous systems and the liver. It is prescribed in solutions for intramuscular injections. (See alsoVITAMINS; ANEMIA; and COBALAMINS.)

REFERENCES

Smith, L. Vitamin B12. Moscow, 1962. (Translated from English.)
Friedrich, W. Vitamin B12 und Verwandte Corrinoide, 3rd ed. Stuttgart, 1975.

I. P. RUDAKOVA

cyanocobalamin

[¦sī·ə·nō·kō′bal·ə·mən]
(biochemistry)
vitamin B12
References in periodicals archive ?
Under terms of the agreement, Cardinal Health is detailing Nascobal through a network of 50 direct sales representatives who will regularly call on more than 6,000 gastroenterologists across the U.
Nastech manufactures Nascobal at its FDA approved, cGMP facility in Hauppauge, New York and intends to manufacture the nasal spray dosage form in commercial quantities upon approval and launch of the product.
Questcor eliminated the unamortized balance of its Nascobal purchased technology upon the divestment of Nascobal in October 2005 and accordingly no amortization expense of purchased technology was recognized in the fourth quarter of 2005.
If a patient is not properly maintained with Nascobal Nasal Spray, intramuscular vitamin B12 is necessary.
Patients with pernicious anemia should be instructed that they will require weekly administration of Nascobal Nasal Spray for the remainder of their lives.
This increase primarily reflects on-going expenditures supporting Strativa sales and marketing, driven chiefly by an increase in the field force and other activities related to the re-launch of Nascobal B12 Nasal Spray, as well as pre-commercialization costs for Zuplenz[TM] and Oravig[TM] in 2009.
This increase primarily reflects on-going expenditures supporting Strativa sales and marketing, driven primarily by an increase in the field force and other activities related to the re-launch of Nascobal B12 Nasal Spray.
3 million and reflects significant one-time cash outflows related to the purchase of Nascobal B12 Nasal Spray (approximately $55 million), the year-to-date repurchase of $13.